Scott P. Runyon

1.5k total citations
77 papers, 1.2k citations indexed

About

Scott P. Runyon is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Scott P. Runyon has authored 77 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cellular and Molecular Neuroscience, 44 papers in Molecular Biology and 20 papers in Pharmacology. Recurrent topics in Scott P. Runyon's work include Receptor Mechanisms and Signaling (35 papers), Neuropeptides and Animal Physiology (33 papers) and Neuroscience and Neuropharmacology Research (13 papers). Scott P. Runyon is often cited by papers focused on Receptor Mechanisms and Signaling (35 papers), Neuropeptides and Animal Physiology (33 papers) and Neuroscience and Neuropharmacology Research (13 papers). Scott P. Runyon collaborates with scholars based in United States, Canada and Italy. Scott P. Runyon's co-authors include F. Ivy Carroll, Rangan Maitra, Hernán A. Navarro, Marco Pravetoni, Yanan Zhang, Danni L. Harris, S. Wayne Mascarella, Brian P. Gilmour, Richard A. Glennon and James B. Thomas and has published in prestigious journals such as PLoS ONE, Biomaterials and The FASEB Journal.

In The Last Decade

Scott P. Runyon

74 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott P. Runyon United States	20	581	473	322	156	147	77	1.2k
Kirsten M. Raehal United States	16	1.2k 2.1×	1.1k 2.3×	205 0.6×	94 0.6×	109 0.7×	17	1.7k
Cullen L. Schmid United States	21	1.5k 2.5×	1.4k 3.0×	204 0.6×	144 0.9×	84 0.6×	29	2.0k
Daniele Bolognini United Kingdom	21	537 0.9×	586 1.2×	813 2.5×	43 0.3×	202 1.4×	29	1.5k
Werner Englberger Germany	22	598 1.0×	592 1.3×	261 0.8×	113 0.7×	254 1.7×	40	1.7k
Barbara L.F. Kaplan United States	27	216 0.4×	525 1.1×	884 2.7×	36 0.2×	108 0.7×	85	1.9k
Santiago Ballaz Ecuador	18	370 0.6×	326 0.7×	108 0.3×	48 0.3×	44 0.3×	46	1.1k
M. Imad Damaj United States	24	552 1.0×	1.0k 2.2×	325 1.0×	192 1.2×	37 0.3×	66	1.6k
Natalya M. Kogan Israel	15	202 0.3×	235 0.5×	650 2.0×	74 0.5×	114 0.8×	27	974
Maria F. Sassano United States	19	1.2k 2.1×	1.7k 3.7×	121 0.4×	141 0.9×	88 0.6×	36	2.6k
Sándor Benyhe Hungary	25	1.6k 2.8×	1.5k 3.2×	293 0.9×	121 0.8×	98 0.7×	157	2.3k

Countries citing papers authored by Scott P. Runyon

Since Specialization

Citations

This map shows the geographic impact of Scott P. Runyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott P. Runyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott P. Runyon more than expected).

Fields of papers citing papers by Scott P. Runyon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott P. Runyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott P. Runyon. The network helps show where Scott P. Runyon may publish in the future.

Co-authorship network of co-authors of Scott P. Runyon

This figure shows the co-authorship network connecting the top 25 collaborators of Scott P. Runyon. A scholar is included among the top collaborators of Scott P. Runyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott P. Runyon. Scott P. Runyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Min, Laura Soverchia, Scott P. Runyon, et al.. (2025). Sex-dependent role of Neuropeptide-S on anxiety, fear conditioning, and alcohol seeking in alcohol preferring rats. Neuropharmacology. 278. 110598–110598.

Gay, Elaine A., et al.. (2025). In vitro biophysical and pharmacological profiling predicts in vivo efficacy of anti-carfentanil monoclonal antibodies in mice. Biochemical and Biophysical Research Communications. 770. 151995–151995. 1 indexed citations

Amato, George, et al.. (2023). Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 93. 129430–129430. 3 indexed citations

Costa, Paula Carvalho, et al.. (2023). RTI-263, a biased neuropeptide S receptor agonist that retains an anxiolytic effect, attenuates cocaine-seeking behavior in rats. Neuropharmacology. 241. 109743–109743. 6 indexed citations

Baehr, Carly, Connor Weidle, Peter B. Rupert, et al.. (2022). Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding. Structure. 31(1). 20–32.e5. 12 indexed citations

Hesk, David, David M. Lindsay, William J. Kerr, et al.. (2020). Synthesis of [³H] and [¹⁴C]genipin. Journal of Labelled Compounds and Radiopharmaceuticals. 63(4). 196–202. 2 indexed citations

Harper, Kathryn M., Sheryl S. Moy, Scott P. Runyon, et al.. (2020). Aplnr knockout mice display sex-specific changes in conditioned fear. Behavioural Brain Research. 400. 113059–113059. 1 indexed citations

Baruffaldi, Federico, Michael D. Raleigh, Samantha J. King, et al.. (2019). Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation. Molecular Pharmaceutics. 16(6). 2364–2375. 13 indexed citations

Kormos, Chad M., Pauline W. Ondachi, Scott P. Runyon, et al.. (2018). Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-N-[1R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic). Journal of Medicinal Chemistry. 61(17). 7546–7559. 4 indexed citations

10.

Ondachi, Pauline W., Chad M. Kormos, Scott P. Runyon, et al.. (2018). Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-7-Hydroxy-N-[(1S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic). Journal of Medicinal Chemistry. 61(17). 7525–7545. 8 indexed citations

11.

Kormos, Chad M., Pauline W. Ondachi, Scott P. Runyon, et al.. (2017). Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor Antagonists. ACS Medicinal Chemistry Letters. 8(7). 742–745. 9 indexed citations

12.

Narayanan, Sanju, Rangan Maitra, Jeffrey R. Deschamps, et al.. (2016). Discovery of a novel small molecule agonist scaffold for the APJ receptor. Bioorganic & Medicinal Chemistry. 24(16). 3758–3770. 24 indexed citations

13.

Kormos, Chad M., Scott P. Runyon, James B. Thomas, et al.. (2016). Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of replacement of the 3-hydroxyphenyl group with pyridine or thiophene bioisosteres. Bioorganic & Medicinal Chemistry. 24(16). 3842–3848. 4 indexed citations

14.

Carroll, F. Ivy, Chad M. Kormos, Rangan Maitra, et al.. (2015). Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents. Bioorganic & Medicinal Chemistry. 23(19). 6379–6388. 14 indexed citations

15.

Perrey, David A., Ann M. Decker, Jun‐Xu Li, et al.. (2015). The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. Bioorganic & Medicinal Chemistry. 23(17). 5709–5724. 16 indexed citations

16.

Thomas, James B., Robert W. Wiethe, O. Srinivas, et al.. (2014). Identification of 1-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1 H -pyrazol-3-yl]carbonyl}amino)cyclohexane Carboxylic Acid as a Selective Nonpeptide Neurotensin Receptor Type 2 Compound. Journal of Medicinal Chemistry. 57(12). 5318–5332. 20 indexed citations

17.

Zhang, Yanan, et al.. (2012). Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats. Pharmacology Biochemistry and Behavior. 103(2). 332–337. 26 indexed citations

18.

Lewin, Anita H., et al.. (2012). Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: Possible confounding effects on in vivo and in vitro studies. Bioorganic & Medicinal Chemistry Letters. 22(21). 6661–6664. 47 indexed citations

19.

Runyon, Scott P. & F. Ivy Carroll. (2006). Dopamine Transporter Ligands: Recent Developments and Therapeutic Potential. Current Topics in Medicinal Chemistry. 6(17). 1825–1843. 50 indexed citations

20.

Westkaemper, Richard B., Scott P. Runyon, Jason E. Savage, Bryan Roth, & Richard A. Glennon. (2001). Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor. Bioorganic & Medicinal Chemistry Letters. 11(4). 563–566. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact